MeSH term
Frequency | Condition_Probility | 4-Hydroxyphenylpyruvate Dioxygenase/*genetics | 2 | 100.0 |
Adolescent | 2 | 0.0 |
Base Sequence | 6 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Female | 9 | 0.0 |
Humans | 22 | 0.0 |
Infant | 2 | 0.0 |
Male | 9 | 0.0 |
Research Support, Non-U.S. Gov't | 19 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Animals | 17 | 0.0 |
Mice | 12 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
Child | 2 | 0.0 |
Exons | 3 | 0.0 |
Introns | 2 | 0.0 |
Kidney/enzymology | 2 | 1.0 |
Liver/enzymology | 4 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Tyrosine/blood | 2 | 11.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Radiation-Sensitizing Agents/*pharmacology | 2 | 6.0 |
DNA Primers | 3 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Adult | 2 | 0.0 |
English Abstract | 5 | 0.0 |
*Photochemotherapy | 4 | 9.0 |
Antineoplastic Agents/*therapeutic use | 2 | 0.0 |
Hematoporphyrin Derivative/therapeutic use | 2 | 100.0 |
Neoplasm Transplantation | 2 | 0.0 |
Rats | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
4-Hydroxyphenylpyruvate Dioxygenase/biosynthesis/*genetics | 2 | 100.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
Dihematoporphyrin Ether | 4 | 66.0 |
Fluorescence | 2 | 0.0 |
*Hematoporphyrin Photoradiation | 2 | 40.0 |
In Vitro | 2 | 0.0 |
Combined Modality Therapy | 2 | 0.0 |
Hematoporphyrins/*therapeutic use | 2 | 66.0 |
Rats, Inbred F344 | 2 | 0.0 |
Hematoporphyrin Derivative | 8 | 88.0 |
Cell Line | 4 | 0.0 |
Hematoporphyrins/*pharmacology | 4 | 80.0 |
Light | 3 | 1.0 |
Lasers | 2 | 1.0 |
Hematoporphyrins/*metabolism | 2 | 66.0 |
Kinetics | 2 | 0.0 |
Spectrometry, Fluorescence | 2 | 0.0 |
Radiation-Sensitizing Agents | 2 | 28.0 |
Tissue Distribution | 2 | 0.0 |
